Aprepitant Oral Suspension and Trastuzumab Injection (Intravenous)
Determining the interaction of Aprepitant Oral Suspension and Trastuzumab Injection (Intravenous) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: trastuzumab
Brand name: Herceptin, Kanjinti, Ogivri
Synonyms: Trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Oral Suspension-Trastuzumab Intravenous
- Aprepitant Oral Suspension-Trastuzumab-anns
- Aprepitant Oral Suspension-Trastuzumab-dkst
- Aprepitant Oral Suspension-Trastuzumab-dkst Intravenous
- Aprepitant Oral Suspension-Trasylol
- Aprepitant Oral Suspension-Travasol
- Trastuzumab Injection (Intravenous)-Aprepitant/Fosaprepitant Dimeglumine
- Trastuzumab Injection (Intravenous)-Apresazide
- Trastuzumab Injection (Intravenous)-Apresoline
- Trastuzumab Injection (Intravenous)-Apresoline Injection
- Trastuzumab Injection (Intravenous)-Apri
- Trastuzumab Injection (Intravenous)-Apriso